CoChat
Sign Up
Cited by 130

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain

Lukiw, Walter J., Alexandrov, Peter N.·2012·Molecular Neurobiology
DOI 10.1007/s12035-012-8234-4PMC PMC3703615
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-012-8234-4

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 56

  1. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set. Physiol Genomics 33:240–256 · DOI · Paper page
  2. Li YY, Cui JG, Dua P, Pogue AI, Bhattacharjee S, Lukiw WJ (2011) Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett 499:109–113 · DOI · Paper page
  3. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835–840 · DOI · Paper page
  4. Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus. Neuroreport 18:297–300 · DOI · Paper page
  5. Lukiw WJ, Pogue AI (2007) Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 101:1265–1269 · DOI
  6. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ (2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by miRNA-146a and NF-kB in stressed human astroglial cells and in Alzheimer’s disease. J Biol Chem 285:38951–38960 · DOI · Paper page
  7. Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex. Neurosci Lett 459:100–104 · DOI · Paper page
  8. Deangelis MM, Silveira AC, Carr EA, Kim IK (2011) Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol 26:77–93 · DOI · Paper page
  9. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R (2001) A gene expression profile of Alzheimer’s disease. DNA Cell Biol 20:683–695 · DOI
  10. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70:462–473 · DOI · Paper page
  11. Lukiw WJ (2004) Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem Res 29:1287–1297 · DOI
  12. Lee JC, Simonyi A, Sun AY, Sun GY (2011) Phospholipase A2 and neural membrane dynamics: implications for Alzheimer’s disease. J Neurochem 116:813–819 · DOI
  13. Lukiw WJ, Bazan NG (2010) Inflammatory, apoptotic, and survival gene signaling in Alzheimer’s disease. A review on the bioactivity of neuroprotectin D1 and apoptosis. Mol Neurobiol 42:10–16 · DOI
  14. Rapoport SI (2005) In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways. Prostaglandins Other Lipid Mediat 77:185–196 · DOI
  15. Valtorta F, Pozzi D, Benfenati F, Fornasiero EF (2011) The synapsins: multitask modulators of neuronal development. Dev Biol 22:378–386 · DOI
  16. Evergren E, Benfenati F, Shupliakov O (2007) The synapsin cycle: a view from the synaptic endocytic zone. J Neurosci Res 85:2648–2656 · DOI
  17. Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P (2009) Complement factor H protects against experimental autoimmune encephalomyelitis. J Immunol 18:4368–4377 · DOI
  18. Song F, Poljak A, Smythe GA, Sachdev P (2009) Plasma biomarkers for mild cognitive impairment and Alzheimer’s disease. Brain Res Rev 61:69–80 · DOI
  19. Alexander JJ, Quigg RJ (2007) The simple design of complement factor H: Looks can be deceiving. Mol Immunol 44:123–132 · DOI
  20. Lukiw WJ (2011) NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol (in press) · DOI · Paper page
  21. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic cid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115:2774–2783 · DOI
  22. Hanke ML, Kielian T (2011) Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 121:367–387 · DOI
  23. Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355 · DOI · Paper page
  24. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139 · DOI
  25. Lukiw WJ, Handley P, Wong L, McLachlan DRC (1992) BC200 and other small RNAs RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res 17:591–597 · DOI
  26. Perron MP, Provost P (2009) Protein components of the microRNA pathway and human diseases. Methods Mol Biol 487(1):369–385
  27. Tsitsiou E, Lindsay MA (2009) microRNAs and the immune response. Curr Opin Pharmacol 9(4):514–520 · DOI
  28. Lukiw WJ, Cui JG, Yuan LY, Bhattacharjee PS, Corkern M, Clement C et al (2010) Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuroreport 21:922–927 · DOI
  29. Madathil SK, Nelson PT, Saatman KE, Wilfred BR (2011) MicroRNAs in CNS injury: potential roles and therapeutic implications. Bioessays 33:21–26 · DOI
  30. Pogue AI, Li YY, Cui JG, Zhao Y, Kruck TPA, Percy ME et al (2009) Characterization of an NF-kB-regulated miRNA-146a in metal-sulfate-stressed human brain cells. J Inorg Biochem 11:156–164
  31. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI (2007) MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) 72:578–582 · DOI
  32. Wang K, Zhang S, Weber J, Baxter D, Galas DJ (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38:7248–7259 · DOI · Paper page
  33. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108:5003–5008 · DOI · Paper page
  34. Lukiw WJ, Pogue AI (2007) Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 101:1265–1269 · DOI
  35. Hill JM, Zhao Y, Clement C, Neumann DM, Lukiw WJ (2009) HSV-1 infection of human brain cells induces miRNA-146a & Alzheimer-type inflammatory signaling. Neuroreport 20:1500–1505 · DOI · Paper page
  36. Zhao Y, Cui JG, Lukiw WJ (2006) Natural secretory products of human neural and microvessel endothelial cells: implications in pathogenic “spreading” and Alzheimer’s disease. Mol Neurobiol 34:181–192 · DOI
  37. Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhattacharjee S, Lukiw WJ (2012) miRNA-155 up-regulation and complement factor H (CFH) deficits in Down’s Syndrome. Neuroreport (in press) · DOI
  38. Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-kB signaling. J Mol Cell Biol 3:159–166 · DOI · Paper page
  39. Sarnico I, Lanzillotta A, Benarese M, Alghisi M, Baiguera C, Battistin L, Spano P, Pizzi M (2009) NF-kB dimers in the regulation of neuronal survival. Int Rev Neurobiol 85:351–362 · DOI
  40. Cai D (2009) NF-kB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle 8:2542–2548 · DOI
  41. Ruland J (2011) Return to homeostasis: down-regulation of NF-κB responses. Nat Immunol 12:709–714 · DOI
  42. Suzuki J, Ogawa M, Muto S, Itai A, Isobe M, Hirata Y, Nagai R (2011) Novel IkB kinase inhibitors for treatment of nuclear factor-kB-related diseases. Expert Opin Investig Drugs 20:395–405 · DOI
  43. Meffert MK, Baltimore D (2005) Physiological functions for brain NF-kB. Trends Neurosci 28:37–43 · DOI
  44. Lukiw WJ, LeBlanc HJ, Carver LA, McLachlan DR, Bazan NG (1998) Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease. J Mol Neurosci 11:67–78 · DOI
  45. Lukiw WJ, Percy ME, Kruck TP (2005) Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem 99:1895–1898 · DOI · Paper page
  46. Hill JM, Lukiw WJ, Gebhardt BM, Higaki S, Loutsch JM, Myles ME, Thompson HW, Kwon BS, Bazan NG, Kaufman HE (2001) Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes 23:273–280 · DOI
  47. Cui JG, Kuroda H, Chandrasekharan NV, Pelaez RP, Simmons DL, Bazan NG, Lukiw WJ (2004) Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem Res 29:1731–1737 · DOI
  48. Coolen M, Bally-Cuif L (2009) Micro RNAs in brain development and physiology. Curr Opin Neurobiol 19:461–470 · DOI
  49. Ma X, Becker Buscaglia LE, Barker JR, Li YY (2011) MicroRNAs in NF-kB signaling. J Mol Cell Biol 3:159–166 · DOI · Paper page
  50. Pogue AI, Cui JG, Li YY, Zhao Y, Culicchia F, Lukiw WJ (2010) Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 476:18–22 · DOI
  51. Lukiw WJ, Bazan NG (1998) Strong nuclear factor-kB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer’s disease superior temporal lobe neocortex. J Neurosci Res 53:583–592 · DOI
  52. Palacios-Pelaez R, Lukiw WJ, Bazan NG (2010) Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol 41:367–374 · DOI
  53. Flannery S, Bowie AG (2010) The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem Pharmacol 80:1981–1991 · DOI
  54. Gan L, Li L (2006) Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity. Immunol Res 35:295–302 · DOI
  55. Xu D, Sharma C, Hemler ME (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 23:3674–3681 · DOI · Paper page
  56. Yáñez-Mó M, Sánchez-Madrid F, Cabañas C (2011) Membrane proteases and tetraspanins. Biochem Soc Trans 39:541–546 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lukiw, W. J., & Alexandrov, P. N.
Venue
Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Published
2012-02-03
Volume
46
Issue
1
Pages
11-19
ISSN
  • 0893-7648
  • 1559-1182
DOI
10.1007/s12035-012-8234-4
PMC
PMC3703615
Cited by
130
References
5
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review